Global Business Corporation
GBC is a commercial corporation focused on development of biosimilar (highly similar biologic) medicines with an emphasis on sustainable biologics manufacturing and increasing access to advanced biologics in frontier markets. The site highlights a research-based pipeline across multiple therapeutic areas and references corporate pages for ESG and business strategy.
Industries
Nr. of Employees
small (1-50)
Global Business Corporation
Products
Biosimilar medicines in development
A pipeline of biosimilar biologic medicines addressing neurology, oncology & haematology, gynaecology & endocrinology, and rheumatology.
Biosimilar medicines in development
A pipeline of biosimilar biologic medicines addressing neurology, oncology & haematology, gynaecology & endocrinology, and rheumatology.
Services
Services and internal activities related to research and development of biosimilar medicines and pipeline management.
Design and branding work including logo sets, color palettes, typography guidelines, digital mockups, and application to marketing assets and landing pages (portfolio examples shown).
Services and internal activities related to research and development of biosimilar medicines and pipeline management.
Design and branding work including logo sets, color palettes, typography guidelines, digital mockups, and application to marketing assets and landing pages (portfolio examples shown).
Expertise Areas
- Biosimilar development
- Neurology therapeutics
- Oncology and haematology therapeutics
- Gynaecology and endocrinology therapeutics
Key Technologies
- Biosimilar/biologic therapeutics
- Biologics manufacturing and process development
- Sustainable manufacturing technologies
- Digital design and mockup tooling